Dna sequence variant
Pro Research Analysisby 
Searched over 200M research papers
Clinical Interpretation of DNA Sequence Variants
Importance of Clinical Interpretation in Genetic Testing
The clinical interpretation of DNA sequence variants is crucial for reporting results from genetic testing. The advent of next-generation sequencing (NGS) has significantly advanced the diagnosis of genetic disorders by identifying numerous DNA sequence variants, many of which are novel and pose challenges for clinical interpretation . The American College of Medical Genetics and Genomics (ACMG) and the Association for Molecular Pathology (AMP) have established guidelines widely adopted by clinical laboratories to standardize the interpretation process . Despite these efforts, subjective professional judgment still plays a role in variant classification, leading to variability in clinical reports .
Standardization Efforts and Protocols
To address these challenges, the ClinGen Sequence Variant Interpretation Working Group and disease-specific variant curation expert panels have developed specifications for the ACMG/AMP recommendations . A step-by-step protocol has been proposed to help clinical laboratory geneticists interpret sequence variants according to these guidelines, enhancing the understanding and quality of genetic testing reports .
Large-Scale Genetic Variation Analysis
Exome Aggregation Consortium (ExAC)
Large-scale reference datasets, such as those generated by the Exome Aggregation Consortium (ExAC), are essential for interpreting DNA sequence changes. ExAC's analysis of exome data from 60,706 individuals revealed an average of one variant every eight bases, highlighting the prevalence of genetic diversity . This dataset has been instrumental in calculating pathogenicity metrics for sequence variants and identifying genes under strong selection against mutations . Such data are invaluable for filtering candidate disease-causing variants and discovering human "knockout" variants in protein-coding genes .
HGVS Nomenclature System
The Human Genome Variation Society (HGVS) has developed a standardized nomenclature system for describing sequence variants, which is critical for consistent reporting and data exchange in DNA diagnostics . The system, updated regularly to remove inconsistencies and tighten definitions, facilitates automatic data processing and ensures accurate communication of genetic information .
Variant Calling Technologies
Next-Generation and Third-Generation Sequencing
Variant calling is a key process in identifying DNA sequence variants. Both next-generation sequencing (NGS) and third-generation sequencing (TGS) technologies are used, with various tools available for different types of variants. Studies have shown that no single variant caller excels in all scenarios, necessitating careful selection based on the specific requirements of the analysis . For instance, DeepVariant outperforms others in InDel calling on TGS data, while TNscope and MuTect2 are superior for somatic variant calling on NGS data .
Structural and Functional Variants
Structural Variants in the Human Genome
Structural variants, including copy number variants (CNVs) and inversions, represent significant sources of genetic variation. Genome assembly comparison has proven effective in identifying these variants, uncovering substantial previously undescribed variation . This approach has revealed complex differences in regions with CNVs, segmental duplications, and repetitive DNA, emphasizing the need for comprehensive annotation strategies .
Functional Consequences of Non-Synonymous Variants
Predicting the functional impact of non-synonymous DNA sequence variants is challenging but essential for understanding genotype-phenotype relationships. Various bioinformatics tools have been developed to predict whether these variants are neutral or disease-causing. Combining results from multiple tools, as demonstrated by the CoVEC approach, improves prediction accuracy .
Regulatory Variants and Disease
Transcription Factor DNA Binding Variation
Most variants associated with complex traits are located in non-coding regulatory regions, affecting transcription factor (TF)-DNA binding motifs. Recent studies indicate that variable TF-DNA interactions are key drivers of phenotypic variation, although the underlying mechanisms are complex and not solely dependent on sequence alterations in TF motifs . Understanding these interactions is crucial for dissecting the molecular roles of non-coding variants in disease susceptibility .
Predicting Impact of Regulatory Variants
A new computational method, deltaSVM, has been developed to predict the impact of regulatory variants. This method quantifies the effect of variants on regulatory sequences and has shown high accuracy in predicting the impact of SNPs on DNase I sensitivity and enhancer activity . DeltaSVM provides a powerful tool for identifying functional regulatory variants implicated in diseases .
Conclusion
The interpretation of DNA sequence variants is a multifaceted process involving clinical guidelines, large-scale genetic data, advanced sequencing technologies, and predictive bioinformatics tools. Standardization efforts and comprehensive datasets like ExAC enhance the accuracy and consistency of variant interpretation. Understanding the functional and regulatory impacts of these variants is crucial for advancing personalized medicine and improving disease diagnosis and treatment.
Sources and full results
Most relevant research papers on this topic